HC Deb 30 March 2000 vol 347 cc247-8W
Mr. David Heath

To ask the Prime Minister (1) if he will make a statement on the outcome of his recent discussions with President Clinton on the subject of the human genome project; [115656]

(2) what recent discussions he has had with the Government of the United States on patent law with regard to genetic sequencing. [115659]

The Prime Minister

[holding answer 27 March 2000]On 14 March President Clinton and I agreed a joint statement on access to information produced by researchers into human genetics. Our statement recognised that research into human genetics offers enormous potential for new ways of understanding, treating and curing disease. It goes on to sayTo realise the full promise of this research, raw fundamental data on the human genome, including the human genome, including the DNA sequence and its variations, should be made freely available to scientists everywhere. Unencumbered access to this information will promote discoveries that will reduce the burden of disease, improve health around the world, and enhance the quality of life for all humankind. Intellectual property protection for gene-based inventions will also play an important role in stimulating the development of important new health care products.

Mr. David Heath

To ask the Prime Minister (1) what proposals he has to seek to amend the law relating to patents with regard to genetic sequencing;[115657]

(2) what recent discussions he has had with (a) other European Union Governments and (b) the European Commission on reform of patent law with regard to genetic sequencing. [115658]

The Prime Minister

[holding answer 27 March 2000]: A European Directive on legal protection of biotechnological inventions which establishes rules for patents relating to gene sequences, has been adopted with the support of the United Kingdom and passed into European law in July 1998. It is due to be implemented in all member states including the United Kingdom by 30 July 2000. Implementation of the Directive will require amendment of the Patents Act 1977. An Order under section 2(2) of the European Communities Act 1972 to make the required changes is being prepared. Comprehensive discussions with the European Commission and all Governments of our European Union partners over several years culminated and are reflected in the adoption of this Directive. No further discussions have taken place since the adoption of this Directive.

Forward to